{
    "Trade/Device Name(s)": [
        "SYNCHRON Systems Creatinine Reagent",
        "SYNCHRON\u00ae Systems Creatinine (CREA) Reagent"
    ],
    "Submitter Information": "Beckman Coulter, Inc.",
    "510(k) Number": "K060935",
    "Predicate Device Reference 510(k) Number(s)": [
        "K042291"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CGX"
    ],
    "Summary Letter Date": "April 28, 2006",
    "Summary Letter Received Date": "April 5, 2006",
    "Submission Date": "April 4, 2006",
    "Regulation Number(s)": [
        "21 CFR 862.1225"
    ],
    "Regulation Name(s)": [
        "Creatinine test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Creatinine"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma",
        "Urine"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "SYNCHRON CX",
        "UniCel DxC SYNCHRON",
        "UniCel DxC 600/800 System(s)"
    ],
    "Method(s)/Technology(ies)": [
        "Sample-blanked method (creatinine-triggered assay)"
    ],
    "Methodologies": [
        "Quantitative determination"
    ],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for SYNCHRON Systems Creatinine Reagent for quantitative creatinine determination using sample-blanked assay on SYNCHRON and UniCel DxC systems",
    "Indications for Use Summary": "For quantitative determination of creatinine in human serum, plasma, or urine to aid in diagnosis and treatment of renal diseases, monitor renal dialysis, and calculate other urine analytes",
    "fda_folder": "Clinical Chemistry"
}